Similar Search Results

Hospitals and the generic versus brand-name prescription decision in the outpatient sector

Pruckner, Gerald J.; Schober, Thomas - 2016

Healthcare payers try to reduce costs by promoting the use of cheaper generic drugs. We show that there are strong interrelations in drug prescriptions between the inpatient and the outpatient sector using a large administrative dataset from Austria. Patients with prior hospital visits have a...

Persistent link: https://www.econbiz.de/10011519140

Generic drug in Indonesia : why physicians and pharmacists matters

Amelia, Amelia; Ronald, Ronald - In: International journal of monetary economics and finance 11 (2018) 3, pp. 307-315

Persistent link: https://www.econbiz.de/10011971199

Hospitals and the generic versus brand-name prescription decision in the outpatient sector

Pruckner, Gerald J.; Schober, Thomas - 2016

Healthcare payers try to reduce costs by promoting the use of cheaper generic drugs. We show strong interrelations in drug prescriptions between the inpatient and outpatient sectors by using a large administrative dataset from Austria. Patients with prior hospital visits have a significantly...

Persistent link: https://www.econbiz.de/10011570769

Collusion in the US generic drug industry

Clark, Robert; Fabiilli, Christopher Anthony; Lasio, Laura - 2021

We study cartels that operated in the US generic drug industry, leveraging quarterly Medicaid data from 2011-2018 and a difference-in-differences approach comparing the evolution of prices of allegedly collusive drugs with a group of competitive control drugs. Our analysis highlights (i) the...

Persistent link: https://www.econbiz.de/10012670921

Emerging pharmaceutical companies from China, India, and Brazil : from generic drugs to innovation strategies

Cahen, Fernanda Ribeiro - In: Innovation from emerging markets : from copycats to leaders, (pp. 222-255). 2021

Persistent link: https://www.econbiz.de/10012815671

Generic drug shortages and undifferentiated competition

Choi, Seung-chan - In: Advances in National Brand and Private Label Marketing …, (pp. 53-59). 2024

Persistent link: https://www.econbiz.de/10015077056

Does bad medical news reduce preferences for generic drugs?

Hermosilla, Manuel; Ching, Andrew - In: Journal of marketing 88 (2024) 1, pp. 160-178

Persistent link: https://www.econbiz.de/10014582843

Do patents really foster innovation in the pharmaceutical sector? : results from an evolutionary, agent-based model

Dosi, Giovanni; Palagi, Elisa; Roventini, Andrea; … - 2021

The role of the patent system in the pharmaceutical sector is highly debated also due to its strong public health … different configurations of the patent system upon innovation and competition. The model is able to replicate the main stylized …

Persistent link: https://www.econbiz.de/10012654995

Pay-for-delay settlements and patent expansion practices

Manganelli, Anton-Giulio - In: Information economics and policy : IEP 64 (2023), pp. 1-12

Persistent link: https://www.econbiz.de/10014451120

Patents, human rights, and access to medicines

Oke, Emmanuel - 2022

Patent rights on pharmaceutical products are one of the factors responsible for the lack of access to affordable … patent rights and human rights law, contending that, in order to preserve their patent policy space and secure access to …, implementation, interpretation, and enforcement of their national patent laws. Through a comprehensive analysis of court decisions …

Persistent link: https://www.econbiz.de/10013272609